Epigenetics in Lung Cancer
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype SuppressionJNCI: Journal of the National Cancer Institute, 2001
- Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancerOncogene, 2001
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI: Journal of the National Cancer Institute, 2000
- Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 2000
- In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesisProceedings of the National Academy of Sciences, 1999
- Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosisProceedings of the National Academy of Sciences, 1998
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- DNA methylation and epigenetic mechanismsCell Biochemistry and Biophysics, 1989
- CpG-rich islands and the function of DNA methylationNature, 1986